During the past decade, Shikoku Region Facility conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shikoku Region Facility" are "Acute Lung Injury" (1 trials), "Malignant Tumor" (1 trials), "Stroke" (1 trials) and "Systemic Inflammatory Response Syndrome" (1 trials). Many other conditions were trialed in "Shikoku Region Facility" in a lesser frequency.

Most popular intervention types in "Shikoku Region Facility" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ONO-2506" (1 trials), "ONO-7436" (1 trials) and "Sivelestat sodium hydrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shikoku Region Facility" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Shikoku Region Facility". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Shikoku Region Facility, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shikoku Region Facility, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".